Following long-term HER2 siRNA treatment, the population distribution remains largely the same, without any detectable emergence of a CD24-/CD44+ population (Fig 2B), suggesting no enrichment of tumor initiating cells. This evidence concerns the gene ERBB2 and neoplasm.